Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Real-time Boerse Muenchen 12:14:13 25/09/2025 pm IST			5-day change	1st Jan Change
0.0985 ^EUR	-0.51%		-.--%	-

01/09	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris

Market Cap	61.46L 71.46L 57.99L 52.83L 98.75L 68Cr 99.65L 6.91Cr 2.66Cr 35Cr 2.68Cr 2.62Cr 110.07Cr	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	5.92Cr 6.89Cr 5.59Cr 5.09Cr 9.52Cr 658.65Cr 9.61Cr 67Cr 26Cr 334.08Cr 26Cr 25Cr 1.06TCr	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

01/09	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
07/01	CARMAT: To Watch Today
06/01	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
06/01	Carmat Announces Liquidation and Delisting
02/12	Only Takeover Bid for Carmat Approved by Court
02/12	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
02/12	Carmat receives takeover bid	RE
04/11	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
15/25/15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/25/15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/25/15	Carmat says liquidation review postponed until Nov 25	RE
01/25/01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE

09/25/09	Carmat: Invest Securities raises target price
11/25/11	Carmat: Invest Securities still a buyer, but cuts TP
04/25/04	Carmat: Invest Securities slightly lowers its target
09/25/09	Carmat: Invest Securities upgrades to buy
09/25/09	Carmat: Oddo BHF reduces its price target

CARMAT Share Price Boerse Muenchen

Stocks

CXT

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation : CARMAT

Chart: CARMAT

Latest news : CARMAT

Analysts' recommendations : CARMAT

Press Releases : CARMAT

News in other languages : CARMAT

Quotes and Performance

Managers and Directors : CARMAT

Medical Devices & Implants

Financials

Company Profile

02/12	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
04/11	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/25/29	CARMAT : Inside Information / Other news releases	PU
29/25/29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/25/15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

04/03	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
07/01	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
07/01	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
07/01	CARMAT : A suivre aujourd'hui
07/01	Les records continuent à tomber en bourse

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	01/09/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	12/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	02/01/2017
Michael Mack BRD	Director/Board Member	79	20/04/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-0.51%	-.--%	-	-	70.8L
STRYKER CORPORATION	-0.66%	-11.63%	-31.10%	-10.63%	10TCr
SMITH & NEPHEW PLC	-1.66%	-5.22%	-29.15%	-5.53%	1.17TCr
GLAUKOS CORPORATION	+0.01%	-4.40%	+93.98%	+123.34%	1TCr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.34%	-3.93%	-55.03%	-71.49%	399.05Cr
DOUBLE MEDICAL TECHNOLOGY INC.	-2.84%	-6.02%	-30.57%	+30.74%	239.98Cr
INSPIRE MEDICAL SYSTEMS, INC.	+4.72%	+12.79%	-14.07%	-68.17%	196.94Cr
INSIGHT LIFETECH CO., LTD.	+1.47%	-6.79%	-	-	181.49Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-2.10%	-3.88%	-24.51%	-29.82%	152.9Cr
Average	-0.30%	-3.81%	-12.92%	-4.51%	1.71TCr
Weighted average by Cap.	-0.67%	-10.17%	-22.01%	-2.35%

	2023	2024
Net sales	38.37L 44.62L 36.2L 32.98L 61.65L 43Cr 62.21L 4.31Cr 1.66Cr 22Cr 1.68Cr 1.64Cr 69Cr	73.44L 85.4L 69.29L 63.13L 1.18Cr 82Cr 1.19Cr 8.25Cr 3.18Cr 41Cr 3.21Cr 3.14Cr 131.53Cr
Net income	-5.39Cr -6.26Cr -5.08Cr -4.63Cr -8.66Cr -598.87Cr -8.73Cr -61Cr -23Cr -303.76Cr -24Cr -23Cr -964.82Cr	-5.14Cr -5.98Cr -4.85Cr -4.42Cr -8.26Cr -571.37Cr -8.33Cr -58Cr -22Cr -289.81Cr -22Cr -22Cr -920.51Cr
Net Debt	4.96Cr 5.77Cr 4.68Cr 4.27Cr 7.98Cr 551.81Cr 8.05Cr 56Cr 21Cr 279.89Cr 22Cr 21Cr 889Cr	5.31Cr 6.17Cr 5.01Cr 4.56Cr 8.53Cr 590.32Cr 8.61Cr 60Cr 23Cr 299.42Cr 23Cr 23Cr 951.05Cr